ABUS vs ITW · P/E 5.4, rev $6.2M vs P/E 22, rev $16.04B
Arbutus Biopharma Corp (ABUS) versus Illinois Tool Works Inc (ITW) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported ITW revenue for 2025-12-31 was $16.04B. Net income was $3.07B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Not investment advice. Open the ABUS and ITW stock pages for the full models.
Not investment advice.